Page last updated: 2024-09-02

oxymatrine and Melanoma

oxymatrine has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
He, L; Hu, Y; Li, X; Niu, H; Ou, Y; Wang, S1
Jiang, H; Jin, J; Liu, H; Lu, L; Zhang, Y; Zhu, X1

Other Studies

2 other study(ies) available for oxymatrine and Melanoma

ArticleYear
Oxymatrine inhibits melanoma development by modulating the immune microenvironment and targeting the MYC/PD-L1 pathway.
    International immunopharmacology, 2023, Volume: 124, Issue:Pt B

    Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Melanoma; Mice; Tumor Microenvironment

2023
The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells.
    Anti-cancer drugs, 2010, Volume: 21, Issue:5

    Topics: Acetylcysteine; Alkaloids; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Melanoma; Oxidative Stress; Quinolizines; Reactive Oxygen Species

2010